Federal Supply Schedule V797D70257
Award Date 9/30/17
Last Date to Order 9/29/22
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to GC Biopharma USA, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through January 14, 2025. The FSS contract is for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. Additionally, a Blanket Purchase Agreement (BPA) was awarded under this FSS contract with a ceiling value of...
- This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime contractor...
- This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Provepharm Inc., a foreign-owned, self-certified small disadvantaged business organization. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a performance period ending on March 15, 2023. It was awarded on October 10, 2022 and is not set aside...
- The subject contract is a Federal Supply Schedule (FSS) award to Pharmaceutical Specialties Inc. by the Veterans Integrated Service Network 12, a civilian agency. The FSS contract is under Schedule 65-IB, covering Drugs, Pharmaceuticals, and Hematology Related Products. The contract has a ceiling value of $11,713,300.00 and a period of performance through November 30, 2026. The purpose of this FSS contract is to provide the procuring agency with access to a broad range of pharmaceutical and drug...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Alpha Cognition USA, Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a period of performance from April 3, 2025 to September 30, 2025. The contract has a ceiling value of $25,000.00 and was awarded as a multiple award, with no set-asides used. The scope of the contract appears to focus on the provision of drugs,...
- This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Bioxcel Therapeutics, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through February 14, 2023. The contract is for an "Interim Agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products." This indicates the contract provides for the delivery of pharmaceutical and related...
- AstraZeneca Pharmaceuticals LP was awarded a multiple-award Indefinite Delivery/Indefinite Quantity contract by the Centers for Disease Control and Prevention (CDC) on December 31, 2025, with a ceiling value of $9.3 million and a period of performance extending through February 28, 2027. This contract supports the Vaccine for Children (VFC) program, which was established under the Omnibus Budget Reconciliation Act of 1993 to provide influenza vaccines to eligible pediatric populations...
- This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. government, to Genericus, Inc. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple award contract with a ceiling value of $850,000.00 and a period of performance ending on December 14, 2029. As a Federal Supply Schedule contract, it allows for the procurement of the specified products and...
- This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Arcutis Biotherapeutics, Inc. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through January 14, 2023. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows federal agencies to procure...
- This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Aquestive Therapeutics, Inc. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products, under FSS Contract 65 I B. The contract has a ceiling value of $1,000,000.00 and a period of performance extending to March 31, 2030. As a multiple award FSS contract, this vehicle allows the VA and other federal agencies to procure the specified pharmaceutical and drug...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D70257Federal Supply Schedule
- Blanket Purchase Agreements
- 22Federal Contract Awards
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Posted 9/26/17
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Supplemental Agreement for work within scope | $0 | 9/15/20 | |
| P00004 | Supplemental Agreement for work within scope | $0 | 12/18/19 | |
| P00003 | Other Administrative Action | $0 | 9/27/19 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 12/6/18 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 12/5/17 |
Name | Description | Awardee | Potential Value | AwardDate | LastDateToOrder | Updated At |
|---|---|---|---|---|---|---|
V797D70257-VA797E17A0004 | Lexicon Pharmaceuticals, Inc. | $2.5m | 10/13/17 | 9/28/20 | 9/28/20 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order V797D70257-36C24518F1608 | Lexicon Pharmaceuticals, Inc. | $3.9k | 1/26/18 | 1/31/18 | 1/26/18 | |
Delivery Order V797D70257-36C25218F2467 | Lexicon Pharmaceuticals, Inc. | $3.9k | 2/21/18 | 2/28/18 | 2/21/18 | |
Delivery Order V797D70257-36C24519F0303 | Lexicon Pharmaceuticals, Inc. | $11.0k | 1/3/19 | 1/8/19 | 1/3/19 | |
Delivery Order V797D70257-36C24518F3685 | Lexicon Pharmaceuticals, Inc. | $11.1k | 8/23/18 | 8/27/18 | 8/23/18 | |
Delivery Order V797D70257-36C24518F3786 | Lexicon Pharmaceuticals, Inc. | $10.1k | 9/21/18 | 9/26/18 | 9/21/18 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Roxane Laboratories, Inc. 900 Ridgebury Road Ridgefield, CT 06877 | 65IB | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 8/12/16, 2:39 PM |